FOR IMMEDIATE RELEASE December 4, 2025 HEADLINE South Korea Emerges as Global Leader in Hair Loss Innovation, with Broader Access and Potential Cost Coverage SUMMARY South Korea is rapidly becoming a global hub for innovation in hair-loss treatment, with multiple emerging therapies advancing through clinical use and research. Dermatologists note that Korea’s regulatory environment and healthcare system may allow patients earlier access and lower out-of-pocket costs compared

FOR IMMEDIATE RELEASE December 4, 2025 HEADLINE PP-405 Gains Attention as a Novel Small-Molecule Therapy for Hair Loss Following Early Clinical Signals SUMMARY PP-405, an investigational topical small-molecule therapy for hair loss, is drawing interest after early clinical data suggested meaningful hair regrowth with a favorable safety profile. Dermatologists are watching closely as this new mechanism advances through clinical development for androgenetic alopecia. BACKGRO

FOR IMMEDIATE RELEASE December 4, 2025 HEADLINE New Phase III Data for Breezula® (Clascoterone) Shows Strong Hair-Count Gains and Robust Safety in Androgenetic Alopecia Trials SUMMARY Topical androgen receptor inhibitor Breezula® (clascoterone 5% solution) has met its co-primary endpoints in two Phase III trials, showing substantial improvements in scalp hair count over vehicle — raising hopes for a new non-systemic therapy for pattern hair loss. New York hair-loss special

FOR IMMEDIATE RELEASE December 2, 2025 Taipei, Taiwan HEADLINE New Taiwanese Mouse Study Identifies Fat-Cell Signaling Pathway That Triggers Hair Regrowth SUMMARY A newly released study from researchers at National Taiwan University (NTU) shows that topical application of specific fatty acids stimulated rapid and robust hair regrowth in hairless mice. New York dermatologist Dr. Dennis Porto notes that while the findings are compelling, translation to humans remains uncerta